Metabolic and microbial modulation of the large intestine ecosystem by non-absorbed diet phenolic compounds: A review

Molecules

Volumn 20, Issue 9, 2015, Pages 17429-17468

  Mosele, Juana I ^a   Macià, Alba ^a   Motilva, Maria José ^a  

^a UNIVERSITY OF LLEIDA   (Spain)

Author keywords

Colon metabolites; Gut fermentation; Microbiota; Phenolic compounds

Indexed keywords

ANTIINFLAMMATORY AGENT; ANTIOXIDANT; POLYPHENOL;

ANIMAL; BACTERIUM; BIOAVAILABILITY; CHEMISTRY; FERMENTATION; HUMAN; INTESTINE ABSORPTION; LARGE INTESTINE; METABOLISM; MICROBIOLOGY; MICROFLORA;

ANIMALS; ANTI-INFLAMMATORY AGENTS; ANTIOXIDANTS; BACTERIA; BIOLOGICAL AVAILABILITY; FERMENTATION; HUMANS; INTESTINAL ABSORPTION; INTESTINE, LARGE; MICROBIOTA; POLYPHENOLS;

EID: 84942758923     PISSN: None     EISSN: 14203049     Source Type: Journal    
DOI: 10.3390/molecules200917429     Document Type: Review

References (191)

1. Acosta-Estrada, B.A.; Gutiérrez-Uribe, J.A.; Serna-Saldívar, S.O. Bound phenolics in foods, a review. Food Chem. 2014, 152, 46-55.
2. Mosele, J.I.; Macia, A.; Romero, M.P.; Motilva, M.J.; Rubió, L. Application of in vitro gastrointestinal digestion and colonic fermentation models to pomegranate products (juice, pulp and peel extract) to study the stability and catabolism of phenolic compounds. J. Funct. Foods 2015, 14, 529-540.
3. Tomás-Barberán, F.A.; García-Villalba, R.; González-Sarrías, A.; Selma, M.V.; Espín, J.C. Ellagic acid metabolism by human gut microbiota: Consistent observation of three urolithin phenotypes in intervention trials, independent of food source, age, and health status. J. Agric. Food Chem. 2014, 62, 6535-6538.
4. González-Barrio, R.; Borges, G.; Mullen, W.; Crozier, A. Bioavailability of anthocyanins and ellagitannins following consumption of raspberries by healthy humans and subjects with an ileostomy. J. Agric. Food Chem. 2010, 58, 3933-3939.
5. Cummings, J.H.; Wiggins H.S.; Jenkins, D.J.A.; Houston, H.; Jivraj, T.; Drasar, B.S.; Hill, M.J. Influence of diets high and low in animal fat on bowel habit, gastrointestinal transit time, fecal microflora, bile acid, and fat excretion. J. Clin. Investig. 1978, 61, 953-963.
6. Soobrattee, M.A.; Neergheen, V.S.; Luximon-Ramma, A.; Aruoma, O.I.; Bahorun, T. Phenolics as potential antioxidant therapeutic agents: Mechanism and actions. Mutat. Res. Fundam. Mol. Mech. Mutagen. 2005, 579, 200-213.
7. Oz, H.S.; Chen, T.; de Villiers, W.J.S. Green tea polyphenols and sulfasalazine have parallel anti-inflammatory properties in colitis models. Front. Immunol. 2013, 4, 132.
8. Rodríguez-Ramiro, I.; Ramos, S.; López-Oliva, E.; Agis-Torres, A.; Bravo, L.; Goya L.; Martín, M.A. Cocoa polyphenols prevent inflammation in the colon of azoxymethane-treated rats and in TNF-a-stimulated Caco-2 cells. Br. J. Nutr. 2013, 110, 206-215.
9. Anhê, F.F.; Roy, D.; Pilon, G.; Dudonné, S.; Matamoros, S.; Varin, T.V.; Garofalo, C.; Moine, Q.; Desjardins, Y.; Levy, E.; et al. A polyphenol-rich cranberry extract protects from diet-induced obesity, insulin resistance and intestinal inflammation in association with increased Akkermansia spp. population in the gut microbiota of mice. Gut 2015, 64, 872-883.
10. Larrosa, M.; Yañéz-Gascón, M.J.; Selma, M.V.; González-Sarriás, A.; Toti, S.; Cerón, J.J.; Tomás-Barberán, F.; Dolara, P.; Espín, J.C. Effect of a low dose of dietary resveratrol on colon microbiota, inflammation and tissue damage in a DSS-induced colitis rat model. J. Agric. Food Chem. 2009, 57, 2211-2220.
11. Roowi, S.; Stalmach, A.; Mullen, W.; Lean, M.E.J.; Edwards, C.A.; Crozier, A. Green tea flavan-3-ols: Colonic degradation and urinary excretion of catabolites by humans. J. Agric. Food Chem. 2010, 58, 1296-1304.
12. Barroso, E.; van de Wiele, T.; Jiménez-Girón, A.; Muñoz-González, I.; Martín-Alvarez, P.J.; Moreno-Arribas, M.V.; Bartolomé, B.; Peláez, C.; Martínez-Cuesta, M.C.; Requena, T. Lactobacillus plantarum IFPL935 impacts colonic metabolism in a simulator of the human gut microbiota during feeding with red wine polyphenols. Appl. Microbiol. Biotechnol. 2014, 98, 6805-6815.
13. Monagas, M.; Urpi-Sarda, M.; Sánchez-Patán, F.; Llorach, R.; Garrido, I.; Gómez-Cordovés, C.; Andres-Lacueva, C.; Bartolomé, B. Insights into the metabolism and microbial biotransformation of dietary flavan-3-ols and the bioactivity of their metabolites. Food Funct. 2010, 1, 233-253.
14. Sánchez-Patán, F.; Cueva, C.; Monagas, M.; Walton, G.E.; Gibson, G.R.; Martín-Álvarez, P.J.; Victoria Moreno-Arribas, M.; Bartolomé, B. Gut microbial catabolism of grape seed flavan-3-ols by human faecal microbiota. Targeted analysis of precursor compounds, intermediate metabolites and end-products. Food Chem. 2012, 131, 337-347.
15. Cueva, C.; Sánchez-Patán, F.; Monagas, M.; Walton, G.E.; Gibson, G.R.; Martín-Álvarez, P.J.; Bartolomé, B.; Moreno-Arribas, M.V. In vitro fermentation of grape seed flavan-3-ol fractions by human faecal microbiota: Changes in microbial groups and phenolic metabolites. FEMS Microb. Ecol. 2013, 83, 792-805.
16. Van Duynhoven, J.; van der Hooft, J.J.J.; van Dorsten, F.A.; Peters, S.; Foltz, M.; Gomez-Roldan, V.; Vervoort, J.; de Vos, R.C.H.; Jacobs, D.M. Rapid and sustained systemic circulation of conjugated gut microbial catabolites after single-dose black tea extract consumption. J. Proteome Res. 2014, 13, 2668-2678.
17. Van Dorsten, F.A.; Peters, S.; Gross, G.; Gomez-Roldan, V.; Klinkenberg, M.; de Vos, R.C.; Vaughan, E.E.; van Duynhoven, J.P.; Possemiers, S.; van de Wiele, T.; et al. Gut microbial metabolism of polyphenols from black tea and red wine/grape juice is source-specific and colon-region dependent. J. Agric. Food Chem. 2012, 60, 11331-11342.
18. Margalef, M.; Pons, Z.; Bravo, F.I.; Muguerza, B.; Arola-Arnal, A. Plasma kinetics and microbial biotransformation of grape seed flavanols in rats. J. Funct. Foods 2015, 12, 478-488.
19. Jaganath, I.B.; Mullen, W.; Lean, M.E.J.; Edwards, C.A.; Crozier, A. In vitro catabolism of rutin by human fecal bacteria and the antioxidant capacity of its catabolites. Free Radic. Biol. Med. 2009, 47, 1180-1189.
20. Peng, X.; Zhang, Z.; Zhang, N.; Liu, L.; Li, S.; Wei, H. In vitro catabolism of quercetin by human fecal bacteria and the antioxidant capacity of its catabolites. Food Nutr. Res. 2014, 58, 23406.
21. Schneider, H.; Blaut, M. Anaerobic degradation of flavonoids by Eubacterium ramulus. Archives Microb. 2000, 173, 71-75.
22. Mullen, W.; Rouanet, J.-M.; Auger, C.; Teissèdre, P.-L.; Caldwell, S.T.; Hartley, R.C.; Lean, M.E.J.; Edwards, C.A.; Crozier, A. Bioavailability of [2-14C]quercetin-4′-glucoside in rats. J. Agric. Food Chem. 2008, 56, 12127-12137.
23. Rechner, A.R.; Smith, M.A.; Kuhnle, G.; Gibson, G.R.; Debnam, E.S.; Srai, S.K.S.; Moore, K.P.; Rice-Evans, C.A. Colonic metabolism of dietary polyphenols: Influence of structure on microbial fermentation products. Free Radic. Biol. Med. 2004, 36, 212-225.
24. Lin, Y.; Wu, B.; Li, Z.; Hong, T.; Chen, M.; Tan, Y.; Jiang, J.; Huang, C. Metabolite identification of myricetin in rats using HPLC coupled with ESI-MS. Chromatographia 2012, 75, 655-660.
25. Du, L.-Y.; Zhao, M.; Xu, J.; Qian, D.-W.; Jiang, S.; Shang, E.-X.; Guo, J.-M.; Liu, P.; Su, S.-L.; Duan, J.-A.; et al. Identification of the metabolites of myricitrin produced by human intestinal bacteria in vitro using ultra-performance liquid chromatography/quadrupole time-of-flight mass spectrometry. Expert Opin. Drug Metab. Toxicol. 2014, 10, 921-931.
26. Mosele, J.I.; Martín-Peláez, S.; Macià, A.; Farràs, M.; Valls, R.M.; Catalán, U.; Motilva, M.J. Study of the catabolism of thyme phenols combining in vitro fermentation and human intervention. J. Agric. Food Chem. 2014, 62, 10954-10961.
27. Pereira-Caro, G.; Borges, G.; Ky, I.; Ribas, A.; Calani, L.; Del Rio, D.; Clifford, M.N.; Roberts, S.A.; Crozier, A. In vitro colonic catabolism of orange juice (poly)phenols. Mol. Nutr. Food Res. 2015, 59, 465-475.
28. Miyake, Y.; Yamamoto, K.; Osawa, T. Metabolism of antioxidant in lemon fruit (Citrus limon BURM. f.) by human intestinal bacteria. J. Agric. Food Chem. 1997, 45, 3738-3742.
29. Hanske, L.; Loh, G.; Sczesny, S.; Blaut, M.; Braune, A. The bioavailability of apigenin-7-glucoside is influenced by human intestinal microbiota in rats. J. Nutr. 2009, 139, 1095-1102.
30. Braune, A.; Gütschow, M.; Engst, W.; Blaut, M. Degradation of quercetin and luteolin by Eubacterium ramulus. Appl. Env. Microb. 2001, 67, 5558-5567.
31. Matthies, A.; Blaut, M.; Braune, A. Isolation of a human intestinal bacterium capable of daidzein and genistein conversion. Appl. Env. Microb. 2009, 75, 1740-1744.
32. Matthies, A.; Loh, G.; Blaut, M.; Braune, A. Daidzein and genistein are converted to equol and 5-hydroxy-equol by human intestinal slackia isoflavoniconvertens in gnotobiotic rats. J. Nutr. 2012, 142, 40-46.
33. Coldham, N.G.; Darby, C.; Hows, M.; King, L.J.; Zhang, A.-Q.; Sauer, M.J. Comparative metabolism of genistin by human and rat gut microflora: Detection and identification of the end-products of metabolism. Xenobiotica 2002, 32, 45-62.
34. Walsh, K.R.; Haak, S.J.; Bohn, T.; Tian, Q.; Schwartz, S.J.; Failla, M.L. Isoflavonoid glucosides are deconjugated and absorbed in the small intestine of human subjects with ileostomies. Am. J. Clin. Nutr. 2007, 85, 1050-1056.
35. Setchell, K.D.R.; Brown, N.M.; Lydeking-Olsen, E. The clinical importance of the metabolite equol-A clue to the effectiveness of soy and its isoflavones. J. Nutr. 2002, 132, 3577-3584.
36. Aura, A.-M.; Martin-Lopez, P.; O'Leary, K.A.; Williamson, G.; Oksman-Caldentey, K.-M.; Poutanen, K.; Santos-Buelga, C. In vitro metabolism of anthocyanins by human gut microflora. Eur. J. Nutr. 2005, 44, 133-142.
37. González-Barrio, R.; Edwards, C.A.; Crozier, A. Colonic catabolism of ellagitannins, ellagic acid, and raspberry anthocyanins: In vivo and in vitro studies. Drug Metab. Disposition 2011, 39, 1680-1688.
38. Hidalgo, M.; Oruna-Concha, M.J.; Kolida, S.; Walton, G.E.; Kallithraka, S.; Spencer, J.P.E.; Gibson, G.R.; de Pascual-Teresa, S. Metabolism of anthocyanins by human gut microflora and their influence on gut bacterial growth. J. Agric. Food Chem. 2012, 60, 3882-3890.
39. Forester, S.C.; Waterhouse, A.L. Identification of cabernet sauvignon anthocyanin gut microflora metabolites. J. Agric. Food Chem. 2008, 56, 9299-9304.
40. Fleschhut, J.; Kratzer, F.; Rechkemmer, G.; Kulling, S.E. Stability and biotransformation of various dietary anthocyanins in vitro. Eur. J. Nutr. 2006, 45, 7-18.
41. Tomás-Barberán, F.; García-Villalba, R.; Quartieri, A.; Raimondi, S.; Amaretti, A.; Leonardi, A.; Rossi, M. In vitro transformation of chlorogenic acid by human gut microbiota. Mol. Nutr. Food Res. 2014, 58, 1122-1131.
42. Ludwig, I.A.; Paz de Peña, M.; Concepción, C.; Alan, C. Catabolism of coffee chlorogenic acids by human colonic microbiota. BioFactors 2013, 39, 623-632.
43. Gonthier, M.-P.; Verny, M.-A.; Besson, C.; Rémésy, C.; Scalbert, A. Chlorogenic acid bioavailability largely depends on its metabolism by the gut microflora in rats. J. Nutr. 2003, 133, 1853-1859.
44. Snelders, J. Olaerts, H., Dornez, E. Van de Wiele, T. Aura, A.-M. Vanhaecke, L. Delcour, J.A. Courtin, C.M. Structural features and feruloylation modulate the fermentability and evolution of antioxidant properties of arabinoxylanoligosaccharides during in vitro fermentation by human gut derived microbiota. J. Funct. Foods 2014, 10, 1-12.
45. Bialonska, D.; Ramnani, P.; Kasimsetty, S.G.; Muntha, K.R.; Gibson, G.R.; Ferreira, D. The influence of pomegranate by-product and punicalagins on selected groups of human intestinal microbiota. Int. J. Food Microb. 2010, 140, 175-182.
46. Espín, J.C.; González-Barrio, R.; Cerdá, B.; López-Bote, C.; Rey, A.I.; Tomás-Barberán, F.A. Iberian pig as a model to clarify obscure points in the bioavailability and metabolism of ellagitannins in humans. J. Agric. Food Chem. 2007, 55, 10476-10485.
47. García-Villalba, R.; Beltrán, D.; Espín, J.C.; Selma, M.V.; Tomás-Barberán, F.A. Time course production of urolithins from ellagic acid by human gut microbiota. J. Agric. Food Chem. 2013, 61, 8797-8806.
48. Selma, M.V.; Beltrán, D.; García-Villalba, R.; Espín, J.C.; Tomás-Barberán, F.A. Description of urolithin production capacity from ellagic acid of two human intestinal Gordonibacter species. Food Funct. 2014, 5, 1779-1784.
49. Bode, L.M.; Bunzel, D.; Huch, M.; Cho, G.-S.; Ruhland, D.; Bunzel, M.; Bub, A.; Franz, C.M.A.P.; Kulling, S.E. In vivo and in vitro metabolism of trans-resveratrol by human gut microbiota. Am. J. Clin. Nutr. 2013, 97, 295-309.
50. Rotches-Ribalta, M.; Andres-Lacueva, C.; Estruch, R.; Escribano, E.; Urpi-Sarda, M. Pharmacokinetics of resveratrol metabolic profile in healthy humans after moderate consumption of red wine and grape extract tablets. Pharmacol. Res. 2012, 66, 375-382.
51. Xie, L.-H.; Akao, T.; Hamasaki, K.; Deyama, T.; Hattori, M. Biotransformation of pinoresinol diglucoside to mammalian lignans by human intestinal microflora, and isolation of Enterococcus faecalis strain PDG-1 responsible for the transformation of (+)-pinoresinol to (+)-lariciresinol. Chem. Pharm. Bull. 2003, 51, 508-515.
52. Eeckhaut, E.; Struijs, K.; Possemiers, S.; Vincken, J.-P.; de Keukeleire, D.; Verstraete, W. Metabolism of the lignan macromolecule into enterolignans in the gastrointestinal lumen as determined in the simulator of the human intestinal microbial ecosystem. J. Agric. Food Chem. 2008, 56, 4806-4812.
53. Aura, A.M.; Oikarinen, S.; Mutanen, M.; Heinonen, SM.; Adlercreutz, H.C.T.; Virtanen, H.; Poutanen, K.S. Suitability of a batch in vitro fermentation model using human faecal microbiota for prediction of conversion of flaxseed lignans to enterolactone with reference to an in vivo rat model. Eur. J. Nutr. 2006, 45, 45-51.
54. Heinonen, S.; Nurmi, T.; Liukkonen, K.; Poutanen, K.; Wähälä, K.; Deyama, T.; Nishibe, S.; Adlercreutz, H. In vitro metabolism of plant lignans: New precursors of mammalian lignans enterolactone and enterodiol. J. Agric. Food Chem. 2001, 49, 3178-3186.
55. Mosele, J.I.; Martín-Peláez, S.; Macia A.; Farràs, M.; Valls, R.M.; Catalán, U.; Motilva, M.J. Faecal microbial metabolism of olive oil phenolic compounds: In vitro and in vivo approaches. Mol. Nutr. Food Res. 2014, 58, 1809-1819.
56. Corona, G.; Tzounis, X.; Dessi M.A.; Deiana, M.; Debnam, E.S.; Visioli, F.; Spencer, J.P.E. The fate of olive oil polyphenols in the gastrointestinal tract: Implications of gastric and colonic microflora-dependent biotransformation. Free Radic. Res. 2006, 40, 647-658.
57. Lin, P.; Qian, W.; Wang, X.; Cao, L.; Li, S.; Qian, T. The biotransformation of oleuropein in rats. Biomed. Chromatogr. 2013, 27, 1162-1167.
58. Pero, R.W. Health consequences of catabolic synthesis of hippuric acid in humans. Curr. Clin. Pharmacol. 2010, 5, 67-73.
59. Lees, H.J.; Swann, J.R.; Wilson, I.D.; Nicholson, J.K.; Holmes, E. Hippurate: The natural history of a mammalian-microbial cometabolite. J. Proteome Res. 2013, 12, 1527-1546.
60. Zheng, X.; Xie, G.; Zhao, A.; Zhao, L.; Yao, C.; Chiu, N.H.L.; Zhou, Z.; Bao, Y.; Jia, W.; Nicholson, J.K.; et al. The footprints of gut microbial-mammalian co-metabolism. J. Proteome Res. 2011, 10, 5512-5522.
61. De Boever, P.; Deplancke, B.; Verstraete, W. Fermentation by gut microbiota cultured in a simulator of the human intestinal microbial ecosystem is improved by supplementing a soygerm powder. J. Nutr. 2000, 130, 2599-2606.
62. Stalmach, A.; Edwards, C.A.; Wightman, J.D.; Crozier, A. Gastrointestinal stability and bioavailability of (poly)phenolic compounds following ingestion of Concord grape juice by humans. Mol. Nutr. Food Res. 2012, 56, 497-509.
63. Verbeke, K.A.; Boobis, A.R.; Chiodini, A.; Edwards, C.A.; Franck, A.; Kleerebezem, M.; Nauta, A.; Raes, J.; van Tol, E.A.F.; Tuohy, K.M. Towards microbial fermentation metabolites as markers for health benefits of prebiotics. Nutr. Res. Rev. 2015, 28, 42-66.
64. Macfarlane, G.T.; Gibson, G.R.; Beatty, E.; Cummings, J.H. Estimation of short-chain fatty acid production from protein by human intestinal bacteria based on branched-chain fatty acid measurements. FEMS Microb. Ecol. 1992, 10, 81-88.
65. Smith, E.A.; Macfarlane, G.T. Dissimilatory amino acid metabolism in human colonic bacteria. Anaerobe 1997, 3, 327-337.
66. Van Nuenen, M.H.M.C.; Venema, K.; van der Woude, J.C.J.; Kuipers, E.J. The metabolic activity of fecal microbiota from healthy individuals and patients with inflammatory bowel disease. Dig. Dis. Sci. 2004, 49, 485-491.
67. Tiihonen, K.; Ouwehand, A.C.; Rautonen, N. Effect of overweight on gastrointestinal microbiology and immunology: Correlation with blood biomarkers. Br. J. Nutr. 2010, 103, 1070-1078.
68. Wong, J.M.W.; de Souza, R.; Kendall, C.W.C.; Emam, A.; Jenkins, D.J.A. Colonic health: Fermentation and short chain fatty acids. J. Clin. Gastroent. 2006, 40, 235-243.
69. Barcelo, A.; Claustre, J.; Moro, F.; Chayvialle, J.-A.; Cuber, J.-C.; Plaisancie P. Mucin secretion is modulated by luminal factors in the isolated vascularly perfused rat colon. Gut 2000, 46, 218-224.
70. Clausen, M.R.; Mortensen, P.B. Kinetic studies on the metabolism of short-chain fatty acids and glucose by isolated rat colonocytes. Gastroenterology 1994, 106, 423-432.
71. Waldecker, M.; Kautenburger, T.; Daumann, H.; Busch, C.; Schrenk, D. Inhibition of histone-deacetylase activity by short-chain fatty acids and some polyphenol metabolites formed in the colon. J. Nutr. Biochem. 2008, 19, 587-593.
72. Monleón, D.; Manuel Morales, J.; Barrasa, A.; López, J.A.; Vázquezc, C.; Celda, B. Metabolite profiling of fecal water extracts from human colorectal cancer. NMR Biomed. 2009, 22, 342-348.
73. Balamurugan, R.; Rajendiran, E.; George, S.; Samuel, G.V.; Ramakrishna, B.S. Real-time polymerase chain reaction quantification of specific butyrate-producing bacteria, Desulfovibrio and Enterococcus faecalis in the feces of patients with colorectal cancer. J. Gastroenterol. Hepatol. (Aust.) 2008, 23, 1298-1303.
74. Kanazawa, K.; Konishi, F.; Mitsuoka, T.; Terada, A.; Itoh, K.; Narushima, S.; Kumemura, M.; Kimura, H. Factors influencing the development of sigmoid colon cancer: Bacteriologic and biochemical studies. Cancer 1996, 77, 1701-1706.
75. Jiang, Z.; Fanger, G.R.; Banner, B.F.; Woda, B.A.; Algate, P.; Dresser, K.; Xu, J.; Reed, S.G.; Rock, K.L.; Chu, P.G. A dietary enzyme: α-Methylacyl-CoA racemase/P504S is overexpressed in colon carcinoma. Cancer Detect. Prev. 2003, 27, 422-426.
76. Parkar, S.G.; Trower, T.M.; Stevenson, D.E. Fecal microbial metabolism of polyphenols and its effects on human gut microbiota. Anaerobe 2013, 23, 12-19.
77. Zampa, A.; Silvil, S.; Servili, M.; Montedoro, G.; Orpianesi, C.; Cresci, A. In vitro modulatory effects of colonic microflora by olive oil iridoids. Microb. Ecol. Health Dis. 2006, 18, 147-153.
78. Bazzocco, S.; Mattila, I.; Guyot, S.; Renard, C.M.G.C.; Aura, A.-M. Factors affecting the conversion of apple polyphenols to phenolic acids and fruit matrix to short-chain fatty acids by human faecal microbiota in vitro. Eur. J. Nutr. 2008, 47, 442-452.
79. Brune, A.; Miambi, E.; Breznak, J.A. Roles of oxygen and the intestinal microflora in the metabolism of lignin-derived phenylpropanoids and other monoaromatic compounds by termites. Appl. Environ. Microbiol. 1995, 61, 2688-2695.
80. Kosmala, M.; Zdunczyk, Z.; Juskiewicz, J.; Jurgonski, A.; Karlinska, E.; Macierzynski, J.; Janczak, R.; Rój, E. Chemical composition of defatted strawberry and raspberry seeds and the effect of these dietary ingredients on polyphenol metabolites, intestinal function, and selected serum parameters in rats. J. Agric. Food Chem. 2015, 63, 2989-2996.
81. Hara, H.; Orita, N.; Hatano, S.; Ichikawa, H.; Hara, Y.; Matsumoto, N.; Kimura, Y.; Terada, A.; Mitsuoka, T. Effect of tea polyphenols on fecal flora and fecal metabolic products of pigs. J. Vet. Med. Sci. Jpn. Soc. Vet. Sci. 1995, 57, 45-49.
82. Jacobs, D.M.; Deltimple, N.; van Velzen, E.; van Dorsten, F.A.; Bingham, M.; Vaughan, E.E.; van Duynhoven, J. 1H NMR metabolite profiling of feces as a tool to assess the impact of nutrition on the human microbiome. NMR Biomed. 2008, 21, 615-626.
83. Da Silva, J.K.; Cazarin, C.B.B.; Colomeu, T.C.; Batista, T.G.; Meletti, L.M.M.; Paschoal, J.A.R.; Bogusz Júnior, S.; Furlan, M.F.; Reyes, F.G.R.; Augusto, F.; et al. Antioxidant activity of aqueous extract of passion fruit (Passiflora edulis) leaves: In vitro and in vivo study. Food Res. Int. 2013, 53, 882-890.
84. Etxeberria, U.; Ariasc, N.; Boque N.; Macarullac, M.T.; Portillo, M.P.; Martíneza, J.A.; Milagro, F.I. Reshaping faecal gut microbiota composition by the intake of trans-resveratrol and quercetin in high-fat sucrose diet-fed rats. J. Nutr. Biochem. 2015, 26, 651-660.
85. Mosele, J.I.; Gosalbes, M.J.; Macia A.; Rubio L.; Vázquez-Castellanos, J.F.; Jiménez Hernández, N.; Moya, A.; Latorre, A.; Motilva, M.J. Effect of daily intake of pomegranate juice on fecal microbiota and feces metabolites from healthy volunteers. Mol. Nutr. Food Res. 2015, in press.
86. Koecher, K.J.; Noack, J.A.; Timm, D.A.; Klosterbuer, A.S.; Thomas, W.; Slavin, J.L. Estimation and interpretation of fermentation in the Gut: Coupling results from a 24 h batch in vitro system with fecal measurements from a human intervention feeding study using fructo-oligosaccharides, inulin, gum acacia, and pea fiber. J. Agric. Food Chem. 2014, 62, 1332-1337.
87. Jakobsdottir, G.; Nilsson, U.; Blanco, N.; Sterner, O.; Nyman, M. Effects of soluble and insoluble fractions from bilberries, black currants, and raspberries on short-chain fatty acid formation, anthocyanin excretion, and cholesterol in rats. J. Agric. Food Chem. 2014, 62, 4359-4368.
88. Juskiewicz, J.; Milala, J.; Jurgonski, A.; Król, B.; Zdunczyk, Z. Consumption of polyphenol concentrate with dietary fructo oligosaccharides enhances cecal metabolism of quercetin glycosides in rats. Nutrition 2011, 27, 351-357.
89. Aprikian, O.; Duclos, V.; Guyot, S.; Besson, C.; Manach, C.; Bernalier, A.; Morand, C.; Rémésy, C.; Demigné, C. Apple pectin and a polyphenol-rich apple concentrate are more effective together than separately on cecal fermentations and plasma lipids in rats. J. Nutr. 2003, 133, 1860-1865.
90. Wallace, A.J.; Eady, S.L.; Hunter, D.C.; Skinner, M.A.; Huffman, L.; Ansell, J.; Blatchford, P.; Wohlers, M.; Herath, T.D.; Hedderley, D.; et al. No difference in fecal levels of bacteria or short chain fatty acids in humans, when consuming fruit juice beverages containing fruit fiber, fruit polyphenols, and their combination. Nutr. Res. 2015, 35, 23-34.
91. Kosmala, M.; Kolodziejczyk, K.; Zdunczyk, Z.; Juskiewicz, J.; Boros, D. Chemical composition of natural and polyphenol-free apple pomace and the effect of this dietary ingredient on intestinal fermentation and serum lipid parameters in rats. J. Agric. Food Chem. 2011, 59, 9177-9185.
92. Zdunczyk, Z.; Juskiewicz, J.; Estrella, I. Cecal parameters of rats fed diets containing grapefruit polyphenols and inulin as single supplements or in a combination. Nutrition 2006, 22, 898-904.
93. Kosmala, M.; Zdunczyk, Z.; Karlinska, E.; Juskiewicz, J. The effects of strawberry, blackcurrant, and chokeberry extracts in a grain dietary fiber matrix on intestinal fermentation in rats. Food Res. Int. 2014, 64, 752-761.
94. Fotschki, B.; Milala, J.; Jurgonski, A.; Karlinska, E.; Zdunczyk, Z.; Juskiewicz, J. Strawberry ellagitannins thwarted the positive effects of dietary fructooligosaccharides in rat cecum. J. Agric. Food Chem. 2014, 62, 5871-5880.
95. Wang, D.; Williams, B.A.; Ferruzzi, M.G.; D'Arcy, B.R. Different concentrations of grape seed extract affect in vitro starch fermentation by porcine small and large intestinal inocula. J. Sci. Food Agric. 2013, 93, 276-283.
96. Kemperman, R.A.; Gross, G.; Mondot, S.; Possemiers, S.; Marzorati, M.; van de Wiele, T.; Dore J.; Vaughan, E.E. Impact of polyphenols from black tea and red wine/grape juice on a gut model microbiome. Food Res. Int. 2013, 53, 659-669.
97. Aura, A.-M.; Niemi, P.; Mattila, I.; Niemela K.; Smeds, A.; Tamminen, T.; Faulds, C.; Buchert, J.; Poutanen, K. Release of small phenolic compounds from Brewer's spent grain and its lignin fractions by human intestinal microbiota in vitro. J. Agric. Food Chem. 2013, 61, 9744-9753.
98. Mc Neil, N.I. The contribution of the large intestine to energy supplies in man. Am. J. Clin. Nutr. 1984, 39, 338-342.
99. Schwiertz, A.; Taras, D.; Schäfer, K.; Beijer, S.; Bos, N.A.; Donus, C.; Hardt, P.D. Microbiota and SCFA in lean and overweight healthy subjects. Obesity 2009, 18, 190-195.
100. Ley, R.E.; Turnbaugh, P.J.; Klein, S.; Gordon, J.I. Microbial ecology: Human gut microbes associated with obesity. Nature 2006, 444, 1022-1023.
101. Noratto, G.D.; Garcia-Mazcorro, J.F.; Markel, M.; Martino, H.S.; Minamoto, Y.; Steiner, J.M.; Byrne, D.; Suchodolski, J.S.; Mertens-Talcott, S.U. Carbohydrate-free peach (Prunus persica) and plum (Prunus domestica) juice affects fecal microbial ecology in an obese animal model. PLoS ONE 2014, 9, e101723.
102. Macdonald, I.A.; Bokkenheuser, V.D.; Winter, J.; McLernon, A.M.; Mosbach, E.H. Degradation of steroids in the human gut. J. Lipid Res. 1983, 24, 675-700.
103. Hirano, S.; Masuda, N.; Oda, H.; Imamura, T. Transformation of bile acids by mixed microbial cultures from human feces and bile acid transforming activities of isolated bacterial strains. Microb. Immunol. 1981, 25, 271-282.
104. Dewei, R.; Ling, L.; Schwabacher, A.W.; Young, J.W.; Beitz, D.C. Mechanism of cholesterol reduction to coprostanol by Eubacterium coprostanoligenes ATCC 51222. Steroids 1996, 61, 33-40.
105. Montilla, P.; Espejo, I.; Muñoz, M.C.; Bujalance, I.; Muñoz-Castañeda, J.R.; Túnez, I. Effect of red wine on oxidative stress and hypercholesterolemia induced by feeding a high-cholesterol diet in rat. J. Physiol. Biochem. 2004, 60, 259-264.
106. Reddy, B.S.; Hanson, D.; Mangat, S.; Mathews, L.; Sbaschnig, M.; Sharma, C.; Simi, B. Effect of high-fat, high-beef diet and of mode of cooking of beef in the diet on fecal bacterial enzymes and fecal bile acids and neutral sterols. J. Nutr. 1980, 110, 1880-1887.
107. Kakiyama, G.; Hylemon, P.B.; Zhou, H.; Pandak, W.M.; Heuman, D.M.; Kang, D.J.; Takei, H.; Nittono, H.; Ridlon, J.M.; Fuchs, M.; et al. Colonic inflammation and secondary bile acids in alcoholic cirrhosis. Am. J. Physiol. Gastrointest. Liver Physiol. 2014, 306, G929-G937.
108. Bernstein, H.; Bernstein, C.; Payne, C.M.; Dvorakova, K.; Garewal, H. Bile acids as carcinogens in human gastrointestinal cancers. Mutat. Res. 2005, 589, 47-65.
109. Bernstein, C.; Holubec, H.; Bhattacharyya, A.K.; Huy Nguyen, H.; Payne, C.M.; Zaitlin, B.; Bernstein, H. Carcinogenicity of deoxycholate, a secondary bile acid. Arch. Toxicol. 2011, 85, 863-871.
110. Nakamura, Y.; Kaihara, A.; Yoshii, K.; Tsumura, Y.; Ishimitsu, S.; Tonogai, Y. Effects of the oral administration of green tea polyphenol and tannic acid on serum and hepatic lipid contents and fecal steroid excretion in rats. J. Health Sci. 2001, 47, 107-117.
111. Sembries, S.; Dongowski, G.; Mehrländer, K.; Will, F.; Dietrich, H. Physiological effects of extraction juices from apple, grape, and red beet pomaces in rats. J. Agric. Food Chem. 2006, 54, 10269-10280.
112. Han, Y.; Haraguchi, T.; Iwanaga, S.; Tomotake, H.; Okazaki, Y.; Mineo, S.; Moriyama, A.; Inoue, J.; Kato, N. Consumption of some polyphenols reduces fecal deoxycholic acid and lithocholic acid, the secondary bile acids of risk factors of colon cancer. J. Agric. Food Chem. 2009, 57, 8587-8590.
113. Caderni, G.; Remy, S.; Cheynier, V.; Morozzi, G.; Dolara, P. Effect of complex polyphenols on colon carcinogenesis. Eur. J. Nutr. 1999, 38, 126-132.
114. Erlejman, A.G.; Fraga, C.G.; Oteiza, P.I. Procyanidins protect Caco-2 cells from bile acid- And oxidant-induced damage. Free Radic. Biol. Med. 2006, 41, 1247-1256.
115. Longpre, J.M.; Loo, G. Protection of human colon epithelial cells against deoxycholate by rottlerin. Apoptosis 2008, 13, 1162-1171.
116. Winter, J.; Nyskohus, L.; Young, G.P.; Hu, Y.; Conlon, M.A.; Bird, A.R.; Topping, D.L.; Le Leu, R.K. Inhibition by resistant starch of red meat-induced promutagenic adducts in mouse colon. Cancer Prev. Res. 2011, 4, 1920-1928.
117. Russell, W.R.; Gratz Sylvia, S.W.; Duncan, H.; Holtrop, G.; Ince, J.; Scobbie, L.; Duncan, G.; Johnstone, A.M.; Lobley, G.E.; Wallace, R.J.; et al. High-protein, reduced-carbohydrate weight-loss diets promote metabolite profiles likely to be detrimental to colonic health. Am. J. Clin. Nutr. 2011, 93, 1062-1072.
118. Vince, A.; Dawson, A.M.; Park, N.; O'Grady, F. Ammonia production by intestinal bacteria. Gut 1973, 14, 171-177.
119. Magee, E.A.; Richardson, C.J.; Hughes, R.; Cummings, J.H. Contribution of dietary protein to sulfide production in the large intestine: An in vitro and a controlled feeding study in humans. Am. J. Clin. Nutr. 2000, 72, 1488-1494.
120. Noack, J.; Kleessen, B.; Lorenz, A.; Blaut, M. The effect of alimentary polyamine depletion on germ-free and conventional rats. J. Nutr. Biochem. 1996, 7, 560-566.
121. Richardson, A.J.; McKain, N.; Wallace, R.J. Ammonia production by human faecal bacteria, and the enumeration, isolation and characterization of bacteria capable of growth on peptides and amino acids. BMC Microb. 2013, 13, doi:10.1186/1471-2180-13-6.
122. Caminero, A.; Nistal, E.; Arias, L.; Vivas, S.; Comino, I.; Real, A.; Sousa, C.; Ruiz de Morales, J.M.; Ferrero, M.A.; Rodríguez-Aparicio, L.B.; et al. A gluten metabolism study in healthy individuals shows the presence of faecal glutenasic activity. Eur. J. Nutr. 2012, 51, 293-299.
123. Blachier, F.; Mariotti, F.; Huneau, J.F.; Tome, D. Effects of amino acid-derived luminal metabolites on the colonic epithelium and physiopathological consequences. Amino Acids 2007, 33, 547-562.
124. Brinkworth, G.D.; Noakes, M.; Clifton, P.M.; Bird, A.R. Comparative effects of very low-carbohydrate, high-fat and high-carbohydrate, low-fat weight-loss diets on bowel habit and faecal short-chain fatty acids and bacterial populations. Br. J. Nutr. 2009, 101, 1493-1502.
125. Yamakoshi, J.; Tokutake, S.; Kikuchi, M.; Kubota, Y.; Konishi, H.; Mitsuoka, T. Effect of proanthocyanidin-rich extract from grape seeds on human fecal flora and fecal odor. Microb. Ecol. Health Dis. 2001, 13, 25-31.
126. Goto, K.; Kanaya, S.; Ishigami, T.; Hara, Y. The effects of tea catechins on fecal conditions of elderly residents in a long-term care facility. J. Nutr. Sci. Vitaminol. 1999, 45, 135-141.
127. Macfarlane, G.T.; Allison, C.; Gibson, G.R. Effect of pH on protease activities in the large intestine. Lett. Appl. Microb. 1988, 7, 161-164.
128. Vince, A.J.; Burridge, S.M. Ammonia production by intestinal bacteria: The effects of lactose, lactulose and glucose. J. Med. Microb. 1980, 13, 177-191.
129. Steck, N.; Mueller, K.; Schemann, M.; Haller, D. Bacterial proteases in IBD and IBS. Gut 2012, 61, 1610-1618.
130. Krogius-Kurikka, L.; Lyra, A.; Malinen, E.; Aarnikunnas, J.; Tuimala, J.; Paulin, L.; Mäkivuokko, H.; Kajander, K.; Palva, A. Microbial community analysis reveals high level phylogenetic alterations in the overall gastrointestinal microbiota of diarrhoea-predominant irritable bowel syndrome sufferers. BMC Gastroenterol. 2009, 9, doi:10.1186/1471-230X-9-95.
131. Etxeberria, U.; Fernández-Quintela, A.; Milagro, F.I.; Aguirre, L.; Martínez, J.A.; Portillo, M.P. Impact of polyphenols and polyphenol-rich dietary sources on gut microbiota composition. J. Agric. Food Chem. 2013, 61, 9517-9533.
132. Joshi, J.R.; Burdman, S.; Lipsky, A.; Yedidia, I. Effects of plant antimicrobial phenolic compounds on virulence of the genus Pectobacterium. Res. Microbiol. 2015, 166, 535-545.
133. Jean-Gilles, D.; Li, L.; Vaidyanathan, V.G.; King, R.; Cho, B.; Worthen, D.R.; Chichester III, C.O.; Seeram, N.P. Inhibitory effects of polyphenol punicalagin on type-II collagen degradation in vitro and inflammation in vivo. Chem.-Biol. Interact. 2013, 205, 90-99.
134. Azuma, T.; Shigeshiro, M.; Kodama, M.; Tanabe, S.; Suzuki, T. Supplemental naringenin prevents intestinal barrier defects and inflammation in colitic mice. J. Nutr. 2013, 143, 827-834.
135. Noda, S.; Tanabe, S.; Suzuki, T. Differential effects of flavonoids on barrier integrity in human intestinal Caco-2 cells. J. Agric. Food Chem. 2012, 60, 4628-4633.
136. Shigeshiro, M.; Tanabe, S.; Suzuki, T. Dietary polyphenols modulate intestinal barrier defects and inflammation in a murine model of colitis. J. Funct. Foods 2013, 5, 949-955.
137. Carrasco-Pozo, C.; Morales, P.; Gotteland, M. Polyphenols protect the epithelial barrier function of Caco-2 cells exposed to indomethacin through the modulation of occludin and zonula occludens-1 expression. J. Agric. Food Chem. 2013, 61, 5291-5297.
138. Macfarlane, S.; Macfarlane, G.T. Session: Short-chain fatty acids. Regulation of short-chain fatty acid production. Proc. Nutr. Soc. 2003, 62, 67-72.
139. Hughes, R.; Pollock, J.R.A.; Bingham, S. Effect of vegetables, tea, and soy on endogenous N-nitrosation, fecal ammonia, and fecal water genotoxicity during a high red meat diet in humans. Nutr. Cancer 2002, 42, 70-77.
140. Denis, M.-C.; Desjardins, Y.; Furtos, A.; Marcil, V.; Dudonne S.; Montoudis, A.; Garofalo, C.; Delvin, E.; Marette, A.; Levy, E. Prevention of oxidative stress, inflammation and mitochondrial dysfunction in the intestine by different cranberry phenolic fractions. Clin. Sci. 2015, 128, 197-212.
141. Bernstein, C.N.; Blanchard, J.F.; Kliewer, E.; Wajda, A. Cancer risk in patients with inflammatory bowel disease: A population-based study. Cancer 2001, 91, 854-862.
142. Bhattacharyya, A.; Chattopadhyay, R.; Mitra, S.;Crowe, S.E. Oxidative stress: An essential factor in the pathogenesis of gastrointestinal mucosal diseases. Physiol. Rev. 2014, 94, 329-354.
143. Denis, M.C.; Furtos, A.; Dudonne S.; Montoudis, A.; Garofalo, C.; Desjardins, Y.; Delvin, E.; Levy, E. Apple peel polyphenols and their beneficial actions on oxidative stress and inflammation. PLoS ONE 2013, 8, e53725.
144. Deiana, M.; Loru, D.; Incani, A.; Rosa, A.; Atzeri, A.; Melis, M.P.; Cabboi, B.; Hollecker, L.; Pinna, M.B.; Argiolas, F.; et al. Wine extracts from Sardinian grape varieties attenuate membrane oxidative damage in Caco-2 cell monolayers. Food Chem. 2012, 134, 2105-2113.
145. Piwowarski, J.P.; Granica, S.; Kiss, A.K. Influence of gut microbiota-derived ellagitannins' metabolites urolithins on pro-inflammatory activities of human neutrophils. Planta Med. 2014, 80, 887-895.
146. Rodríguez-Ramiro, I.; Ramos, S.; Bravo, L.; Goya, L.; Martín, M.T. Procyanidin B2 and a cocoa polyphenolic extract inhibit acrylamide-induced apoptosis in human Caco-2 cells by preventing oxidative stress and activation of JNK pathway. J. Nutr. Biochem. 2011, 22, 1186-1194.
147. Kalaiselvi, P.; Rajashree, K.; Bharathi Priya, L.; Padma, V.V. Cytoprotective effect of epigallocatechin-3-gallate against deoxynivalenol-induced toxicity through anti-oxidative and anti inflammatory mechanisms in HT-29 cells. Food Chem. Toxicol. 2013, 56, 110-118.
148. Mateos-Martín, M.L.; Pérez-Jiménez, J.; Fuguet, E.; Torres, J.L. Profile of urinary and fecal proanthocyanidin metabolites from common cinnamon (Cinnamomum zeylanicum L.) in rats. Mol. Nutr. Food Res. 2012, 56, 671-675.
149. Henning, S.H.; Zhang, Y.; Rontoyanni, V.G.; Huang, J.; Lee, R.-P.; Trang, A.; Nuernberger, G.; Heber, D. Variability in the antioxidant activity of dietary supplements from pomegranate, milk thistle, green tea, grape seed, goji, and acai: Effects of in vitro digestion. J. Agric. Food Chem. 2014, 62, 4313-4321.
150. Fogliano, V.; Corollaro, M.L.; Vitaglione, P.; Napolitano, A.; Ferracane, R.; Travaglia, F.; Arlorio, M.; Costabile, A.; Klinder, A.; Gibson, G. In vitro bioaccessibility and gut biotransformation of polyphenols present in the water-insoluble cocoa fraction. Mol. Nutr. Food Res. 2011, 55, S44-S55.
151. Goñi, I.; Serrano, J. The intake of dietary fiber from grape seeds modifies the antioxidant status in rat cecum. J. Sci. Food Agric. 2005, 85, 1877-1881.
152. Record, I.R.; McInerney, J.K.; Noakes, M.; Bird, A.R. Chocolate consumption, fecal water antioxidant activity, and hydroxyl radical production. Nutr. Cancer 2003, 47, 131-135.
153. Itzkowitz, S.H.; Yio, X. Inflammation and cancer IV. Colorectal cancer in inflammatory bowel disease: The role of inflammation. Am. J. Physiol. Gastrointest. Liver Physiol. 2004, 287, G7-G17.
154. Rogler G. Gastrointestinal and liver adverse effects of drugs used for treating IBD. Best Pract. Res. Clin. Gastroenterol. 2010, 24, 157-165.
155. Taverniti, V.; Fracassetti, D.; del Bo', C.; Lanti, C.; Minuzzo, M.; Klimis-Zacas, D.; Riso, P.; Guglielmetti, S. Immunomodulatory effect of a wild blueberry anthocyanin-rich extract in human caco-2 intestinal cells. J. Agric. Food Chem. 2014 62, 8346-8351.
156. Nunes, C.; Ferreira, E.; Freitas, V.; Almeida, L.; Barbosa, R.M.; Laranjinha, J. Intestinal anti-inflammatory activity of red wine extract: Unveiling the mechanisms in colonic epithelial cells. Food Funct. 2013, 4, 373-383.
157. Serra, D.; Rufino, A.T.; Mendes, A.F.; Almeida, L.M.; Dinis, T.C.P. Resveratrol modulates cytokine-induced jak/stat activation more efficiently than 5-aminosalicylic acid: An in vitro approach. PLoS ONE 2014, 9, e109048.
158. Miene, C.; Weise, A.; Glei, M. Impact of polyphenol metabolites produced by colonic microbiota on expression of COX-2 and GSTT2 in human colon cells (LT97). Nutr. Cancer 2011, 63, 653-662.
159. Piwowarski, J.P.; Granica, S.; Zwierzynska, M.; Stefanska, J.; Schopohl, P.; Melzig, M.F.; Kiss, A.K. Role of human gut microbiota metabolism in the anti-inflammatory effect of traditionally used ellagitannin-rich plant materials. J. Ethnopharmacol. 2014, 155, 801-809.
160. Speca, S.; Giusti, I.; Rieder, F.; Latella, G. Cellular and molecular mechanisms of intestinal fibrosis. World J. Gastroent. 2012, 18, 3635-3661.
161. Giménez-Bastida, J.A.; Larrosa, M.; González-Sarrías, A.; Tomás-Barberán, F.; Espín, J.C.; García-Conesa, M.-T. Intestinal ellagitannin metabolites ameliorate cytokine-induced inflammation and associated molecular markers in human colon fibroblasts. J. Agric. Food Chem. 2012, 60, 8866-887.
162. Sánchez-Fidalgo, S.; Villegas, I.; Aparicio-Soto, M.; Cárdeno, A.; Rosillo, M.T.; González-Benjumea, A.; Marset, A.; López, T.; Maya, I.; Fernández-Bolaños, J.G.; et al. Effects of dietary virgin olive oil polyphenols: Hydroxytyrosyl acetate and 3, 4-dihydroxyphenylglycol on DSS-induced acute colitis in mice. J. Nutr. Biochem. 2015, 26, 513-520.
163. Neyrinck, A.M.; van Hée, V.F.; Bindels, L.B.; de Backer, F.; Cani, P.D.; Delzenne, N.M. Polyphenol-rich extract of pomegranate peel alleviates tissue inflammation and hypercholesterolaemia in high-fat diet-induced obese mice: Potential implication of the gut microbiota. Br. J. Nutr. 2013, 109, 802-809.
164. Boussenna, A.; Cholet, J.; Goncalves-Mendes, N.; Joubert-Zakeyh, J.; Fraisse, D.; Vasson, M.P.; Texiera, O.; Felginesa, C. Polyphenol-rich grape pomace extracts protect against dextran sulfate sodium-induced colitis in rats. J. Sci. Food Agric. 2015, in press.
165. Baumgart, D.C.; Sandborn, W.J. Inflammatory bowel disease: Clinical aspects and established and evolving therapies. Lancet 2007, 369, 1641-1657.
166. Dryden, G.W.; Lam, A.; Beatty, K.; Qazzaz, H.H.; McClain, C.J. A pilot study to evaluate the safety and efficacy of an oral dose of (-)-Epigallocatechin-3-gallate-rich polyphenon E in patients with mild to moderate ulcerative colitis. Inflamm. Bowel Dis. 2013, 19, 1904-1912.
167. Voiosu, T.; Bengus, A.; Dinu, R.; Voiosu, A.M.; Balanescu, P.; Baicus, C.; Diculescu, M.; Voiosu, R.; Mateescu, B. Rapid fecal calprotectin level assessment and the SIBDQ score can accurately detect active mucosal inflammation in IBD patients in clinical remission: A prospective study. J. Gastrointest. Liver Dis. 2014, 23, 273-278.
168. Burri, E.; Beglinger, C.; von Felten, S.; Lehmann, F.S. Fecal calprotectin and the clinical activity index are both useful to monitor medical treatment in patients with ulcerative colitis. Dig. Dis. Sci. 2014, 60, 485-491.
169. Lehmann, F.S.; Trapani, F.; Fueglistaler, I.; Terracciano, L.M.; von Flüe, M.; Cathomas, G.; Zettl, A.; Benkert, P.; Oertli, D.; Beglinger, C. Clinical and histopathological correlations of fecal calprotectin release in colorectal carcinoma. World J. Gastroenterol. 2014, 20, 4994-4999.
170. Gecse, K.B.; Brandse, J.F.; van Wilpe, S.; Löwenberg, M.; Ponsioen, C.; van den Brink, G.; D'haens, G. Impact of disease location on fecal calprotectin levels in Crohn's disease. Scand. J. Gastroenterol. 2015, 50, 841-847.
171. Fallahi, G.; Motamed, F.; Yousefi, A.; Shafieyoun, A.; Najafi, M.; Khodadad, A.; Farhmand, F.; Ahmadvand, A.; Rezaei, N. The effect of probiotics on fecal calprotectin in patients with cystic fibrosis. Turk. J. Pediatr. 2013, 55, 475-478.
172. Goodrich, K.M.; Fundaro, G.; Griffin, L.E.; Grant, A.; Hulver, M.W.; Ponder, M.A.; Neilson, A.P. Chronic administration of dietary grape seed extract increases colonic expression of gut tight junction protein occludin and reduces fecal calprotectin: A secondary analysis of healthy Wistar Furth rats. Nutr. Res. 2012, 32, 787-794.
173. Biedermann, L.; Mwinyi, J.; Scharl, M.; Frei, P.; Zeitz, J.; Kullak-Ublick, G.A.; Vavricka, S.R.; Fried, M.; Weber, A.; Humpf, H.-U.; et al. Bilberry ingestion improves disease activity in mild to moderate ulcerative colitis-An open pilot study. J. Crohn's Colitis 2013, 7, 271-279.
174. Flint, H.J.; Scott, K.P.; Louis, P.; Duncan, S.H. The role of the gut microbiota in nutrition and health. Nat. Rev. Gastroenterol. Hepatol. 2012, 9, 577-589.
175. Larsen, N.; Vogensen, F.K.; van den Berg, F.W.J.; Nielsen, D.S.; Andreasen, A.S.; Pedersen, B.K.; Al-Soud, W.A.; Sørensen, S.J.; Hansen, L.H.; Jakobsen, M. Gut microbiot in human adults with type 2 diabetes differs from non-diabetic adults. PLoS ONE 2010, 5, e9085.
176. Nicholson, J.K.; Holmes, E.; Kinross, J.; Burcelin, R.; Gibson, G.; Jia, W.; Pettersson, S. Host-gut microbiota metabolic interactions. Science 2012, 336, 1262-1267.
177. Hedin, C.; van der Gast, C.J.; Rogers, G.B.; Cuthbertson, L.; McCartney, S.; Stagg, A.J.; Lindsay, J.O.; Whelan, K. Siblings of patients with Crohn's disease exhibit a biologically relevant dysbiosis in mucosal microbial metacommunities. Gut 2015, in press.
178. Wang, J.; Qin, J.; Li, Y.; Cai, Z.; Li, S.; Zhu, J.; Zhang, F.; Liang, S.; Zhang, W.; Guan, Y.; et al. A metagenome-wide association study of gut microbiota in type 2 diabetes. Nature 2012, 490, 55-60.
179. Lee, H.C.; Jenner, A.M.; Lowa, C.S.; Lee., Y.K. Effect of tea phenolics and their aromatic fecal bacterial metabolites on intestinal microbiota. Res. Microb. 2006, 157, 876-884.
180. Hütt, P.; Shchepetova, J.; Lõivukene, K.; Kullisaar, T.; Mikelsaar, M. Antagonistic activity of probiotic lactobacilli and bifidobacteria against entero- And uropathogens. J. Appl. Microb. 2006, 100, 1324-1332.
181. Massot-Cladera, M.; Pérez-Berezo, T.; Franch, A.; Castell, M.; Pérez-Cano, F.J. Cocoa modulatory effect on rat faecal microbiota and colonic crosstalk. Arch. Biochem. Biophys. 2012, 527, 105-112.
182. Gibson, G.R.; Beatty, E.R.; Wang, X.; Cummings, J.H. Selective stimulation of bifidobacteria in the human colon by oligofructose and inulin. Gastroenterology 1995, 108, 975-982.
183. Clavel, T.; Fallani, M.; Lepage, P.; Levenez, F.; Mathey, J.; Rochet, V.; Serezat, M.; Sutren, M.; Henderson, G.; Bennetau-Pelissero, C.; et al. Isoflavones and functional foods alter the dominant intestinal microbiota in postmenopausal women. J. Nutr. 2005, 135, 2786-2792.
184. Tzounis, X.; Rodriguez-Mateos, A.; Vulevic, J.; Gibson, G.R.; Kwik-Uribe, C.; Spencer, J.P. Prebiotic evaluation of cocoa-derived flavanols in healthy humans by using a randomized, controlled, double blind, crossover intervention study. Am. J. Clin. Nutr. 2011, 93, 62-72.
185. Clemente-Postigo, M.; Queipo-Ortuño, M.I.; Boto-Ordoñez, M.; Coin-Aragüez, L.; Roca-Rodríguez, M.M.; Delgado-Lista, J.; Cardona, F.; Andres-Lacueva, C.; Tinahones, F.J. Effect of acute and chronic red wine consumption on lipopolysaccharide concentrations. Am. J. Clin. Nutr. 2013, 97, 1053-1061.
186. Vendrame, S.; Guglielmetti, S.; Riso, P.; Arioli, S.; Klimis-Zacas, D.; Porrini, M. Six-week consumption of a wild blueberry powder drink increases bifidobacteria in the human gut. J. Agric. Food Chem. 2011, 59, 12815-12820.
187. Guglielmetti, S.; Fracassetti, D.; Taverniti, V.; del Bo', C.; Vendrame, S.; Klimis-Zacas, D.; Arioli, S.; Riso, P.; Porrini, M. Differential modulation of human intestinal Bifidobacterium populations after consumption of a wild blueberry (Vaccinium angustifolium) Drink. J. Agric. Food Chem. 2013, 61, 8134-8140
188. Cowan, T.E.; Palmnäs, M.S.A.; Yang, J.; Bomhof, M.R.; Ardell, K.L.; Reimer, R.A.; Vogel, H.J.; Shearer, J. Chronic coffee consumption in the diet-induced obese rat: Impact on gut microbiota and serum metabolomics. J. Nutr. Biochem. 2014, 25, 489-495.
189. Duncan, S.H.; Lobley, G.E.; Holtrop, G.; Ince, J.; Johnstone, A.M.; Louis, P.; Flint, H.J. Human colonic microbiota associated with diet, obesity and weight loss. Int. J. Obes. 2008, 32, 1720-1724.
190. Kotlowski, R.; Bernstein, C.N.; Sepehri, S.; Krause, D.O. High prevalence of Escherichia coli belonging to the B2+D phylogenetic group in inflammatory bowel disease. Gut 2007, 56, 669-675.
191. Bustos, I.; García-Cayuela, T.; Hernández-Ledesma, B.; Peláez, C.; Requena, T.; Martínez-Cuesta, M.C. Effect of flavan-3-ols on the adhesion of potential probiotic lactobacilli to intestinal cells. J. Agric. Food Chem. 2012, 60, 9082-9088.